BioFlag Showcases Innovative Probiotic Solutions at Vitafoods Europe 2025
BARCELONA, Spain, May 20, 2025 /PRNewswire/ -- BIOFLAG CO.,LTD.(Bioflag), a leading probiotic enterprise located in China, proudly unveiled its scientifically validated functional probiotic solutions at Vitafoods Europe 2025, drawing high attention from global media.
At the event, BioFlag highlighted its cutting-edge products, including clinically-proven probiotic strains and finished probiotic products targeting gut health, immune regulation, metabolic health, weight management, oral care, and emotional well-being. The company also introduced customized probiotic solutions tailored to meet stringent European and American standards.
Key innovations include:
Bifidobacterium animalis subsp. lactis BL-99, sourced from their Chinese maternal-infant probiotic strain library. BL-99 holds 12 Chinese invention patents covering gut health, immune regulation, and bone health, and is widely used in infant formula, yogurt, and dietary supplements.
Lactobacillus paracasei K56, isolated from the gut of healthy Chinese infants and clinically proven to reduce body fat, visceral fat, and waist circumference[1]. This strain has received 9 Chinese invention patents and is supported by 12 published research studies.
Bifidobacterium animalis subsp. lactis CP-9, derived from the breast milk of healthy Chinese mothers, patented in China for anti-obesity effects and the treatment or prevention of jaundice.
As a representative of China's probiotics industry, BIOFLAG CO.,LTD. has demonstrated its its full industrial chain capabilities:
A proprietary library of over 3,500 strains and 30+ functional screening platforms
More than 130 patents granted and 100+ scientific papers published
International certifications including GMP, FSSC22000 and HALAL
Production capacity spanning powders, tablets, capsules, and other dosage forms
During the exhibition, BIOFLAG CO.,LTD. reached cooperation intentions with dozens of enterprises and institutions from Europe, North America and other places. A company spokesperson stated, "Drawing on nearly two decades of expertise in functional probiotics, we remain committed to driving innovation in R&D and intelligent manufacturing to deliver superior health solutions to our global customers."
For more information, visit: https://en.bioflag.com/
[1] Kadeer G, Fu W, He Y, et al. Effect of different doses of Lacticaseibacillus paracasei K56 on body fat and metabolic parameters in adult individuals with obesity: a pilot study[J]. Nutr Metab. 2023, 20(1): 16.
View original content to download multimedia:https://www.prnewswire.com/news-releases/bioflag-showcases-innovative-probiotic-solutions-at-vitafoods-europe-2025-302457581.html
SOURCE BIOFLAG CO.,LTD.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Waaree Solar Americas Signs 586 MW Module Supply Agreement with Leading U.S. IPP, Secures $176 Million (INR 1500 Cr) Order
MUMBAI, India and BROOKSHIRE, Texas, May 30, 2025 /PRNewswire/ -- Waaree Solar Americas Inc., the wholly owned U.S. subsidiary of Waaree Energies Limited, India's largest solar PV module manufacturer, has announced the signing of a significant 586 MW solar module supply agreement with a leading U.S.-based independent power producer. Valued at USD 176 million (approx. INR 1500 crore), this landmark project represents a major milestone as Waaree continues to expand its strong presence in the US solar market. The modules will be manufactured at Waaree's state-of-the-art facility in Brookshire, Texas, and are scheduled for delivery during FY 2026–27 across four projects. These modules will leverage several domestically produced components, aligning with the Investment Tax Credit (ITC) guidelines for domestic content requirements and reinforcing the resilience and reliability of the U.S. clean energy supply chain amidst evolving trade and energy policies. "This agreement reflects Waaree's unwavering commitment to building a resilient, robust, and technologically advanced clean energy supply chain in the United States," said Sunil Rathi, President, Waaree Solar Americas. "In a landscape marked by shifting trade dynamics and an increasing emphasis on domestic manufacturing, our Brookshire facility stands uniquely equipped to meet market demand with high-quality, U.S.-made modules. This milestone not only underscores global confidence in Waaree's quality and reliability but also bolsters America's energy transition, enhances job creation, and strengthens long-term energy security." He added, "Our collaboration reflects a mutual commitment to advancing America's energy security objectives through a resilient domestic supply chain, supported by Waaree's extensive manufacturing expertise developed over decades in India. We are proud to contribute to our partner's ambitious project pipeline with our high-performance solar modules." This partnership highlights Waaree's strategic positioning as a highly dependable global PV module manufacturer with a dynamic and resilient supply chain strategically positioned to mitigate trade risks and ensure supply continuity. As US energy demand continues to surge, driven notably by advancements in AI infrastructure and industrial growth, Waaree remains dedicated to supporting its clients and partners by delivering scalable, high-quality clean energy solutions. For Further Information, Please Contact :Manasi Patni – manasipatni@ Photo - View original content to download multimedia: SOURCE Waaree Solar Americas Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23 minutes ago
- Yahoo
New lawsuit seeks to force return of collected tariffs following court ruling
A new lawsuit filed in the U.S. Court of International Trade seeks to force the Trump administration to return tariffs it collected under the president's 'Liberation Day' announcement now that the court has ruled them unlawful. Chapter1 LLC, a Las Vegas-based skincare start-up, said it paid nearly $23,000 under the challenged tariffs when it imported a custom machine to mix its serum and toner products from China. The suit says the company's owner, 25-year-old Ali Shaubzada, ordered the machine in the fall, using most of his savings and business lines of credit. It arrived in the U.S. earlier this month, with the duties outpacing the roughly $16,000 cost of the machine itself. 'To pay for this unexpectedly large bill, Ali had to take out a personal loan,' the complaint reads. The class-action suit seeks to recover Chapter1's tariff payment and the billions in payments made by businesses across the country following Trump's announcements. 'Hundreds of thousands of other American businesses have exactly the same claim, based on exactly the same legal theory, against the United States: Each importer has a claim against the United States for repayment of the tariffs it paid,' the lawsuit states. Chapter1 is represented by Gerstein Harrow. The Hill has reached out to the Justice Department for comment. The suit, filed Thursday, comes a day after the trade court invalidated the bulk of Trump's tariffs. The three-judge panel unanimously ruled that the administration's broad interpretation of the International Emergency Economic Powers Act (IEEPA), a federal law that authorizes the president to impose necessary economic sanctions during a national emergency, is unconstitutional. Trump previously cited trade deficits as emergency justification to impose his 'Liberation Day' tariffs, which imposed a 10 percent rate on all imports and higher, reciprocal tariffs on dozens of U.S. trading partners. Wednesday's ruling also blocked Trump's IEEPA tariffs on Mexico, Canada and China dating back to February that pointed to an influx of fentanyl coming across the border. The U.S. Court of Appeals for the Federal Circuit temporarily lifted the order on Thursday but is expected to issue a new ruling after receiving written arguments from the parties in the coming days. Separately, a federal district judge in the nation's capital blocked Trump's use of IEEPA in response to another lawsuit. The administration has appealed that ruling, too. But the judge provided two weeks before his order goes into effect, meaning that no court injunction is currently blocking any of Trump's tariffs, for now. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
23 minutes ago
- Yahoo
Elon Musk Was Allegedly Taking Large Quantities Of Drugs, Including Ketamine And Adderall, While Advising Trump, According To A Bombshell NYT Report
He forcibly and potentially illegally gained access to wildly sensitive government data that he hired a bunch of unvetted 20-somethings to oversee ― and he was potentially blitzed out of his mind at the same time. Just days after tech billionaire Elon Musk officially left his role as a top adviser to President Donald Trump, the New York Times reported that the tech mogul was consuming large quantities of drugs around the same time he became a fixture on the campaign trail. Related: 18 Major Global Events That American Media Is Ignoring Right Now, And Why They Actually Matter To Us Citing private messages obtained by the Times and interviews with Musk's associates, the outlet reported that Musk took ketamine, ecstasy, psychedelic mushrooms, Ambien, Adderall, and other drugs, and traveled with a daily medication box that held about 20 pills. The CEO of SpaceX and Tesla reportedly took so much Ketamine, a dissociative anesthetic known to induce schizophrenia-like symptoms, that it affected his bladder function. The report is bolstered by a January 2024 Wall Street Journal investigation in which sources close to Musk said they'd witnessed or had direct knowledge of him using LSD, cocaine, ecstasy, mushrooms, and ketamine. Musk's attorney Alex Spiro told the Journal at the time that his client is 'regularly and randomly drug tested at SpaceX' and has 'never failed a test.' It's unclear how, or whether, Musk's consumption habits changed once he became a federal bureaucrat with an office in the White House complex. He didn't address the claims directly at a Friday afternoon press conference in the Oval Office, instead attacking the credibility of the New York Times itself. Related: "MAGAs Are The Dumbest People On This Planet": 26 Tweets About The Sad State Of Politics This Week But he's continued drawing attention for unusual antics, including a chainsaw-wielding appearance at the Conservative Political Action Conference and a Nazi-like hand gesture at Trump's inaugural rally. In April, Rep. Mikie Sherrill (D-N.J.) introduced a bill that would require Musk and his hires at the so-called Department of Government Efficiency to undergo regular drug testing, though the bill has gone nowhere in the Republican-majority House. 'Donald Trump has given billionaire Elon Musk the keys to our government, and with it, access to highly sensitive information — from Treasury and Social Security data to even our most guarded military plans,' Sherrill wrote in a press release. 'Those with access to sensitive information must be thoroughly vetted, clear-eyed, and exercise good judgment.' Asked Friday if he was concerned about drug use by Musk, White House Deputy Chief of Staff Stephen Miller was dismissive ― but notably didn't rule it out. 'The drugs that we're concerned about are the drugs running across the southern border,' he told reporters. The eccentric billionaire has openly discussed his ketamine use in the past. In a 2024 interview with Don Lemon, he said he took 'a small amount' every other week ― but got miffed when Lemon pushed him on it. 'If you've used too much ketamine, you can't really get work done, and I have a lot of work,' he told the journalist at the time. An Atlantic article describing the drug's effects on the body found people build tolerance to it very quickly, requiring ever larger doses to achieve the same high and leading to long-term impaired cognition, including 'delusional thinking, superstitious beliefs, and a sense of specialness and importance.' Those would seem to strike a chord with Sam Harris, a public intellectual and former friend of Musk, who publicly broke with the world's richest man in a post earlier this year. 'Any dispassionate observer of Elon's behavior on Twitter/X can see that there is something seriously wrong with his moral compass, if not his perception of reality,' he article originally appeared on HuffPost. Also in In the News: An Ad Against Far-Right Voters Is Going Viral For Being Both Terrifying And (Kinda) Accurate Also in In the News: Miss USA's 2024 "National Costume" Has Been Revealed, And It's Obviously An Interesting Choice Also in In the News: One Body Language Expert Spotted Something Very Telling When Donald Trump "Held His Own Hand" At His Recent Press Conference
